Phage Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Bacteria Type (Salmonella, Bacteriophage, Streptococcus, E.Coli, Others), By Product (Oral Consumption, External Consumption, Surgical Treatment), By Application (Human Medicines, Veterinary Sciences, Food & Beverage, Others), and By Region

Abstract
The global phage therapy market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include growing incidences of foodborne diseases, anti-biotic infections, and extensive research and development. Phages, also known as bacteriophages, are viruses that only kill and selectively target bacteria. They are the most common biological entities found in nature, effectively fighting, and destroying multi-drug-resistant bacteria. They are used to treat or stop bacterial infections in patients’ bodies. The other factors supporting the market’s growth are, the increasing application of bacteriophage across the food and beverage industry, increasing government investments, rising awareness among the masses, and technological advancements.
High Prevalence Rate of Foodborne Diseases and Anti-Biotic Infections
The rise in the prevalence rate of foodborne diseases and anti-biotic infections across the globe is expected to enhance the market’s growth. Foodborne infections are caused by rotten food, as pathogenic bacteria and viruses are present in them. Bacteriophages are extremely specific to target bacteria. Its usage targets a specific bacterial species and significantly reduces off-target effects on the microbiome or human patient, as bacteriophages do not directly affect human cells. According to the WHO, in 2019, forecasted that about 600 million people will become ill and 420,000 will die because of contaminated food resulting in the loss of 33 million healthy life years. Also, according to the Centers for Disease Control and Prevention (CDC), in 2019, approximately 2 million people in the United States will contract an antibiotic-resistant infection, with at least 23,000 people dying every year.
Increasing Investment
Heavy investments to support phage therapy by the government is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government and lead companies across the globe are investing in clinical trials and R&D Activities, which is propelling the growth of the market. For instance, in 2016, the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health, was granted US$ 5 Mn for 24 research projects to develop advanced therapies such as bacteriophage therapy and others for the treatment of bacterial infections.
Emergence of e-Commerce
Emergence of e-Commerce is bolstering the growth of the market. Several biotech market players are starting to set up online pharmacies of bacteriophage preparations to make phages and phage therapies available across the globe. For instance, in 2020, Ridgeway, a Digital agency, launched a new e-Commerce website for Optibac probiotics, to build on customer compliance and repeat purchase of phage therapy supplements.

Market Segmentation
The global phage therapy market is segmented into bacteria type, products, application, and company. Based on bacteria type, the market is divided into salmonella, bacteriophage, streptococcus, E.coli, and others. Based on products, the market is divided into oral consumption, external consumption, and surgical treatment. Based on application, the market is segmented into human medicines, veterinary sciences, food & beverage, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising prevalence of foodborne diseases and anti-biotic infections in the country.
Market Players
Armata Pharmaceuticals, Inc., iNtODEWORLD, Inc., Phage International, Inc., Fixed-Phage Limited, OCUS BIOSCIENCES, INC., Intralytix, Inc, PhagoMed Biopharma GmbH, PHAGELUX, INC., Pherecydes Pharma SADIR, and Adaptive Phage Therapeutics Inc are some of the leading companies operating in the market.


Report Scope:
In this report, global phage therapy market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
•Phage Therapy Market, By Bacterial Type:
oSalmonella
oBacteriophage
oStreptococcus
oE.Coli
oOthers
•Phage Therapy Market, By Products:
oOral Consumption
oExternal Consumption
oSurgical Treatment
•Phage Therapy Market, By Application:
oHuman Medicines
oVeterinary Sciences
oFood & Beverage
oOthers
•Phage Therapy Market, By Region:
oNorth America
United States
Canada
Mexico
oAsia-Pacific
China
India
Japan
Australia
South Korea
oEurope & CIS
Germany
France
United Kingdom
Spain
Italy
oSouth America
Brazil
Argentina
Colombia
oMiddle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape

Competitive Landscape Detailed analysis of the major companies present in Phage Therapy Market

Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
•Detailed analysis and profiling of additional market players (up to five).

Content
Table of Contents

1.Product Overview
2.Research Methodology
3.Executive Summary
4.Impact of COVID-19 on Global Phage Therapy Market
5.Voice of Customer
6.Clinical Trials Analysis
7.Global Phage Therapy Market Outlook
7.1.Market Size & Forecast
7.1.1.By Value
7.2.Market Share & Forecast
7.2.1.By Bacteria Type (Salmonella, Bacteriophage, Streptococcus, E.Coli, Others)
7.2.2.By Product (Oral Consumption, External Consumption, Surgical Treatment)
7.2.3.By Application (Human Medicines, Veterinary Sciences, Food & Beverage, Others)
7.2.4.By Company (2021)
7.2.5.By Region
7.3.Market Map
8.North America Phage Therapy Market Outlook
8.1.Market Size & Forecast
8.1.1.By Value
8.2.Market Share & Forecast
8.2.1.By Bacteria Type
8.2.2.By Product
8.2.3.By Application
8.2.4.By Country
8.3.North America: Country Analysis
8.3.1.United States Phage Therapy Market Outlook
8.3.1.1.Market Size & Forecast
8.3.1.1.1.By Value
8.3.1.2.Market Share & Forecast
8.3.1.2.1.By Bacteria Type
8.3.1.2.2.By Product
8.3.1.2.3.By Application
8.3.2.Mexico Phage Therapy Market Outlook
8.3.2.1.Market Size & Forecast
8.3.2.1.1.By Value
8.3.2.2.Market Share & Forecast
8.3.2.2.1.By Bacteria Type
8.3.2.2.2.By Product
8.3.2.2.3.By Application
8.3.3.Canada Phage Therapy Market Outlook
8.3.3.1.Market Size & Forecast
8.3.3.1.1.By Value
8.3.3.2.Market Share & Forecast
8.3.3.2.1.By Bacteria Type
8.3.3.2.2.By Product
8.3.3.2.3.By Application
9.Europe Phage Therapy Market Outlook
9.1.Market Size & Forecast
9.1.1.By Value
9.2.Market Share & Forecast
9.2.1.By Bacteria Type
9.2.2.By Product
9.2.3.By Application
9.2.4.By Country
9.3.Europe: Country Analysis
9.3.1.France Phage Therapy Market Outlook
9.3.1.1.Market Size & Forecast
9.3.1.1.1.By Value
9.3.1.2.Market Share & Forecast
9.3.1.2.1.By Bacteria Type
9.3.1.2.2.By Product
9.3.1.2.3.By Application
9.3.2.Germany Phage Therapy Market Outlook
9.3.2.1.Market Size & Forecast
9.3.2.1.1.By Value
9.3.2.2.Market Share & Forecast
9.3.2.2.1.By Bacteria Type
9.3.2.2.2.By Product
9.3.2.2.3.By Application
9.3.3.United Kingdom Phage Therapy Market Outlook
9.3.3.1.Market Size & Forecast
9.3.3.1.1.By Value
9.3.3.2.Market Share & Forecast
9.3.3.2.1.By Bacteria Type
9.3.3.2.2.By Product
9.3.3.2.3.By Application
9.3.4.Italy Phage Therapy Market Outlook
9.3.4.1.Market Size & Forecast
9.3.4.1.1.By Value
9.3.4.2.Market Share & Forecast
9.3.4.2.1.By Bacteria Type
9.3.4.2.2.By Product
9.3.4.2.3.By Application
9.3.5.Spain Phage Therapy Market Outlook
9.3.5.1.Market Size & Forecast
9.3.5.1.1.By Value
9.3.5.2.Market Share & Forecast
9.3.5.2.1.By Bacteria Type
9.3.5.2.2.By Product
9.3.5.2.3.By Application
10.Asia-Pacific Phage Therapy Market Outlook
10.1.Market Size & Forecast
10.1.1.By Value
10.2.Market Share & Forecast
10.2.1.By Bacteria Type
10.2.2.By Product
10.2.3.By Application
10.2.4.By Country
10.3.Asia-Pacific: Country Analysis
10.3.1.China Phage Therapy Market Outlook
10.3.1.1.Market Size & Forecast
10.3.1.1.1.By Value
10.3.1.2.Market Share & Forecast
10.3.1.2.1.By Bacteria Type
10.3.1.2.2.By Product
10.3.1.2.3.By Application
10.3.2.India Phage Therapy Market Outlook
10.3.2.1.Market Size & Forecast
10.3.2.1.1.By Value
10.3.2.2.Market Share & Forecast
10.3.2.2.1.By Bacteria Type
10.3.2.2.2.By Product
10.3.2.2.3.By Application
10.3.3.Japan Phage Therapy Market Outlook
10.3.3.1.Market Size & Forecast
10.3.3.1.1.By Value
10.3.3.2.Market Share & Forecast
10.3.3.2.1.By Bacteria Type
10.3.3.2.2.By Product
10.3.3.2.3.By Application
10.3.4.South Korea Phage Therapy Market Outlook
10.3.4.1.Market Size & Forecast
10.3.4.1.1.By Value
10.3.4.2.Market Share & Forecast
10.3.4.2.1.By Bacteria Type
10.3.4.2.2.By Product
10.3.4.2.3.By Application
10.3.5.Australia Phage Therapy Market Outlook
10.3.5.1.Market Size & Forecast
10.3.5.1.1.By Value
10.3.5.2.Market Share & Forecast
10.3.5.2.1.By Bacteria Type
10.3.5.2.2.By Product
10.3.5.2.3.By Application
11.South America Phage Therapy Market Outlook
11.1.Market Size & Forecast
11.1.1.By Value
11.2.Market Share & Forecast
11.2.1.By Bacteria Type
11.2.2.By Product
11.2.3.By Application
11.2.4.By Country
11.3.South America: Country Analysis
11.3.1.Brazil Phage Therapy Market Outlook
11.3.1.1.Market Size & Forecast
11.3.1.1.1.By Value
11.3.1.2.Market Share & Forecast
11.3.1.2.1.By Bacteria Type
11.3.1.2.2.By Product
11.3.1.2.3.By Application
11.3.2.Argentina Phage Therapy Market Outlook
11.3.2.1.Market Size & Forecast
11.3.2.1.1.By Value
11.3.2.2.Market Share & Forecast
11.3.2.2.1.By Bacteria Type
11.3.2.2.2.By Product
11.3.2.2.3.By Application
11.3.3.Colombia Phage Therapy Market Outlook
11.3.3.1.Market Size & Forecast
11.3.3.1.1.By Value
11.3.3.2.Market Share & Forecast
11.3.3.2.1.By Bacteria Type
11.3.3.2.2.By Product
11.3.3.2.3.By Application
12.Middle East and Africa Phage Therapy Market Outlook
12.1.Market Size & Forecast
12.1.1.By Value
12.2.Market Share & Forecast
12.2.1.By Bacteria Type
12.2.2.By Product
12.2.3.By Application
12.2.4.By Country
12.3.MEA: Country Analysis
12.3.1.South Africa Phage Therapy Market Outlook
12.3.1.1.Market Size & Forecast
12.3.1.1.1.By Value
12.3.1.2.Market Share & Forecast
12.3.1.2.1.By Bacteria Type
12.3.1.2.2.By Product
12.3.1.2.3.By Application
12.3.2.Saudi Arabia Phage Therapy Market Outlook
12.3.2.1.Market Size & Forecast
12.3.2.1.1.By Value
12.3.2.2.Market Share & Forecast
12.3.2.2.1.By Bacteria Type
12.3.2.2.2.By Product
12.3.2.2.3.By Application
12.3.3.UAE Phage Therapy Market Outlook
12.3.3.1.Market Size & Forecast
12.3.3.1.1.By Value
12.3.3.2.Market Share & Forecast
12.3.3.2.1.By Bacteria Type
12.3.3.2.2.By Product
12.3.3.2.3.By Application
12.3.4.Egypt Phage Therapy Market Outlook
12.3.4.1.Market Size & Forecast
12.3.4.1.1.By Value
12.3.4.2.Market Share & Forecast
12.3.4.2.1.By Bacteria Type
12.3.4.2.2.By Product
12.3.4.2.3.By Application
12.3.5.Turkey Phage Therapy Market Outlook
12.3.5.1.Market Size & Forecast
12.3.5.1.1.By Value
12.3.5.2.Market Share & Forecast
12.3.5.2.1.By Bacteria Type
12.3.5.2.2.By Product
12.3.5.2.3.By Application
13.Market Dynamics
13.1.Drivers
13.2.Challenges
14.Market Trends & Developments
15.Competitive Landscape
15.1.Armata Pharmaceuticals, Inc.
15.2.iNtODEWORLD, Inc.
15.3.Phage International, Inc.
15.4.Fixed-Phage Limited
15.5.OCUS BIOSCIENCES, INC.
15.6.Intralytix, Inc
15.7.PhagoMed Biopharma GmbH
15.8.PHAGELUX, INC.
15.9.Pherecydes Pharma SADIR
15.10.Adaptive Phage Therapeutics Inc.
16.Strategic Recommendations